TY  - GEN
AU  - Dickson,Mark A
AU  - Schwartz,Gary K
AU  - Keohan,Mary Louise
AU  - D'Angelo,Sandra P
AU  - Gounder,Mrinal M
AU  - Chi,Ping
AU  - Antonescu,Cristina R
AU  - Landa,Jonathan
AU  - Qin,Li-Xuan
AU  - Crago,Aimee M
AU  - Singer,Samuel
AU  - Koff,Andrew
AU  - Tap,William D
TI  - Progression-Free Survival Among Patients With Well-Differentiated or Dedifferentiated Liposarcoma Treated With CDK4 Inhibitor Palbociclib: A Phase 2 Clinical Trial
SN  - 2374-2445
PY  - 2017///0713
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Cyclin-Dependent Kinase 4
KW  - antagonists & inhibitors
KW  - Cyclin-Dependent Kinase 6
KW  - Disease-Free Survival
KW  - Dose-Response Relationship, Drug
KW  - Female
KW  - Humans
KW  - Liposarcoma
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Piperazines
KW  - administration & dosage
KW  - Protein Kinase Inhibitors
KW  - Pyridines
N1  - Publication Type: Clinical Trial, Phase II; Journal Article
UR  - https://doi.org/10.1001/jamaoncol.2016.0264
ER  -